PTC Therapeutics, Inc.
PTCT· Nasdaq
Released Aug 5, 2020, after the close
10-Q filed Aug 5, 2020, 36 days after period end · 0001070081-20-000128
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $75.24M | $85.52M | $68.74M | $47.89M |
| Net Income | -$181.43M | -$41.79M | -$9.52M | -$17.48M |
| EPS Diluted |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$2.78 |
| -$0.75 |
| -$0.21 |
| -$0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.